HOUSE OF REPRESENTATIVESSENATEDrug Enforcement Administration (DEA)Health & Human Services, Dept of (HHS)White House Office
Specific issues
Discussions regarding legislative and regulatory issues, including appropriations, pertaining to the use and application of psychedelic medicines. Issues pertaining to controlled substances rescheduling
Budget/Appropriations · 2026 Q2
Discussions regarding legislative and regulatory issues, including appropriations, pertaining to the use and application of psychedelic medicines.